CONCOMITANT CORTICOSTEROID USE WITH RAVULIZUMAB IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: PHASE 3 CHAMPION-MG OPENLABEL EXTENSION FINAL RESULTS

被引：0
|
作者：
Nicolle, Michael
Annane, Djillali
Meisel, Andreas
Vu, Tuan
Mantegazza, Renato
Katsuno, Masahisa
Bril, Vera
Aguzzi, Rasha
Frick, Glen
Howard, James F., Jr.
机构：
来源：
MUSCLE & NERVE | 2024年 / 70卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
236
引用
收藏
页码：574 / 575
页数：2
相关论文
共 28 条
  • [1] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Meisel, Andreas
    Annane, Djillali
    Vu, Tuan
    Mantegazza, Renato
    Katsuno, Masahisa
    Aguzzi, Rasha
    Frick, Glen
    Gault, Laura F.
    Howard Jr, James
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3862 - 3875
  • [2] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Andreas Meisel
    Djillali Annane
    Tuan Vu
    Renato Mantegazza
    Masahisa Katsuno
    Rasha Aguzzi
    Glen Frick
    Laura Gault
    James F. Howard
    Journal of Neurology, 2023, 270 : 3862 - 3875
  • [3] LONG-TERM EFFICACY AND SAFETY OF RAVULIZUMAB, A LONG-ACTING TERMINAL COMPLEMENT INHIBITOR, IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: RESULTS FROM THE PHASE 3 CHAMPION MG OPEN-LABEL EXTENSION
    Vu, Tuan
    Meisel, Andreas
    Mantegazza, Renato
    Annane, Djillali
    Katsuno, Masahisa
    Aguzzi, Rasha
    Rampal, Nishi
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 65 : S2 - S3
  • [4] Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
    Habib, Ali A.
    Benatar, Michael
    Vu, Tuan
    Meisel, Andreas
    Attarian, Shahram
    Katsuno, Masahisa
    Liao, Serena
    Beasley, Kathleen N.
    Howard Jr, James F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (12)
  • [5] Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravis
    Miyazaki, Yusei
    Sakushima, Ken
    Niino, Masaaki
    Takahashi, Eri
    Oiwa, Kei
    Naganuma, Ryoji
    Amino, Itaru
    Akimoto, Sachiko
    Minami, Naoya
    Yabe, Ichiro
    Kikuchi, Seiji
    IMMUNOLOGICAL MEDICINE, 2023, 46 (02) : 77 - 83
  • [6] Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis
    Lien, Pei-Wen
    Joshi, Mrinmayee
    Tice, Jeffrey A.
    Agboola, Foluso
    Nikitin, Dmitriy
    Withanawasam, Vinura
    Jatoi, Saira
    Touchette, Daniel R.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (06): : 517 - 527
  • [7] Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis
    Uzawa, Akiyuki
    Ozawa, Yukiko
    Yasuda, Manato
    Oda, Fumiko
    Kojima, Yuta
    Kawaguchi, Naoki
    Kanai, Tetsuya
    Himuro, Keiichi
    Kuwabara, Satoshi
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 339
  • [8] CORRELATION BETWEEN MYASTHENIA GRAVIS-ACTIVITIES OF DAILY LIVING (MG-ADL) AND QUANTITATIVE MYASTHENIA GRAVIS (QMG) ASSESSMENTS OF ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE REFRACTORY GENERALIZED MYASTHENIA GRAVIS IN THE PHASE 3 REGAIN STUDY
    Vissing, John
    O'Brien, Fanny
    Wang, Jing Jing
    Howard, James F., Jr.
    MUSCLE & NERVE, 2018, 58 (02) : E21 - E22
  • [9] Reversible Unilateral Tongue Border Atrophy Associated With Anti-Acetylcholine Receptor Antibody-Positive Myasthenia Gravis
    Carvalho, Ines V.
    Gomes, Fabio
    Almendra, Luciano
    Geraldo, Argemiro
    Matos, Anabela
    NEUROLOGY, 2025, 104 (02)
  • [10] Eculizumab versus rituximab for refractory anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: a single-center experience
    Durmus, H.
    Cakar, A.
    Parman, Y.
    NEUROMUSCULAR DISORDERS, 2024, 43
123